Loading...
XSWX
YPSN
Market cap5.82bUSD
May 13, Last price  
358.00CHF
1D
-0.28%
1Q
-4.41%
Jan 2017
93.51%
Name

Ypsomed Holding AG

Chart & Performance

D1W1MN
XSWX:YPSN chart
No data to show
P/E
62.28
P/S
8.90
EPS
5.75
Div Yield, %
0.56%
Shrs. gr., 5y
1.61%
Rev. gr., 5y
3.86%
Revenues
548m
+10.25%
241,823,000310,588,000277,450,000287,468,000272,580,000254,014,000242,461,000248,593,000244,565,000276,257,000306,632,000336,922,000389,555,000466,119,000453,765,000394,264,000403,656,000464,841,000497,460,000548,457,000
Net income
78m
+52.83%
39,195,00055,648,0002,742,00026,583,00026,166,0009,425,0005,206,0008,500,0001,646,00013,608,00019,395,00035,812,00046,247,00052,060,00060,136,00011,734,0005,811,00023,105,00051,275,00078,366,000
CFO
163m
+26.01%
94,775,00046,365,00030,960,00070,155,00048,404,00022,480,00029,504,00031,055,00015,168,00041,206,00041,381,00076,687,00075,064,00053,269,00059,859,00049,089,00085,828,00085,706,000129,531,000163,224,000
Dividend
Jul 01, 20242 CHF/sh
Earnings
May 20, 2025

Profile

Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for pharmaceutical and biotechnology companies. The company operates in two segments, Ypsomed Delivery Systems and Ypsomed Diabetes Care. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto injectors, patch injectors, and wearable injectors, as well as other smart devices. This segment offers its products under the YDS brand. The Ypsomed Diabetes Care segment sells and trades in insulin pumps, infusion sets, pen needles, blood glucose monitoring systems, accessories, and other day-to-day items for diabetics. This segment offers its products under the mylife brand name. The company offers precision turned parts; and contract manufacturing and other services. It markets its products through biotechnology and pharmaceutical partners, as well as through its own distribution network and independent distributors. It operates in Switzerland, Europe, North America, and internationally. Ypsomed Holding AG was founded in 1984 and is headquartered in Burgdorf, Switzerland.
URL
https://www.ypsomed.com/
IPO date
Sep 22, 2004
Employees
2,059
Domiciled in
CH
Incorporated in
CH

Valuation

Title
CHF in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑03
Income
Revenues
548,457
10.25%
497,460
7.02%
Cost of revenue
467,394
489,115
Unusual Expense (Income)
NOPBT
81,063
8,345
NOPBT Margin
14.78%
1.68%
Operating Taxes
3,506
5,362
Tax Rate
4.33%
64.25%
NOPAT
77,557
2,983
Net income
78,366
52.83%
51,275
121.92%
Dividends
(17,745)
(8,190)
Dividend yield
0.36%
0.32%
Proceeds from repurchase of equity
(190)
34,458
BB yield
0.00%
-1.33%
Debt
Debt current
256,000
157,000
Long-term debt
(7,976)
Deferred revenue
7,976
Other long-term liabilities
40,216
30,072
Net debt
181,983
113,071
Cash flow
Cash from operating activities
163,224
129,531
CAPEX
(116,374)
(169,173)
Cash from investing activities
(195,072)
(122,019)
Cash from financing activities
81,066
1,265
FCF
15,022
(33,564)
Balance
Cash
74,017
25,224
Long term investments
10,729
Excess cash
46,594
11,080
Stockholders' equity
765,225
562,500
Invested Capital
867,358
744,062
ROIC
9.63%
0.42%
ROCE
8.84%
1.10%
EV
Common stock shares outstanding
13,652
13,419
Price
360.50
87.37%
192.40
18.04%
Market cap
4,921,456
90.62%
2,581,751
24.87%
EV
5,103,439
2,694,822
EBITDA
155,929
86,905
EV/EBITDA
32.73
31.01
Interest
5,038
2,310
Interest/NOPBT
6.21%
27.68%